Antibody Information
General Information of This Antibody
| Antibody ID | ANTI0WOLMJ |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | hCL1f |
|||||
| Organization | SOTIO BIOTECH A.S |
|||||
| Synonyms |
hCL1f
Click to Show/Hide
|
|||||
| Antibody Type | Monoclonal antibody (mAb) |
|||||
| Antibody Subtype | Humanized lgG |
|||||
| Antigen Name | Claudin-18.2 (CLDN18.2) |
Antigen Info | ||||
| Click to Show/Hide the Sequence Information of This Antibody | ||||||
| Heavy Chain Sequence |
QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYAMHWVRQAPGQRLEWMGWINAYTGKPTY
AQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCARAVFYGYTMDAWGQGTLVTVSSA STKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSG LYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGP SVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNS TYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDEL TKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQ QGNVFSCSVMHEALHNHYTQKSLSLSPGXXisRorK Click to Show/Hide
|
|||||
| Heavy Chain Varible Domain |
QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYAMHWVRQAPGQRLEWMGWINAYTGKPTY
AQKFQGRVTITRDTSASTAYMELSSLRSEDTAVYYCARAVFYGYTMDAWGQGTLVTVSS Click to Show/Hide
|
|||||
| Heavy Chain CDR 1 |
DYAMH
Click to Show/Hide
|
|||||
| Heavy Chain CDR 2 |
WINAYTGKPTYAQKFQG
Click to Show/Hide
|
|||||
| Heavy Chain CDR 3 |
AVFYGYTMDA
Click to Show/Hide
|
|||||
| Light Chain Sequence |
DIQMTQSPSSLSASVGDRVTITCRASEDIYSNLAWYQQKPGKAPKLLIYSVKRLQDGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCLQGSNFPLTFGQGTKVEIKRTVAAPSVFIFPP SDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLT LSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC Click to Show/Hide
|
|||||
| Light Chain Varible Domain |
DIQMTQSPSSLSASVGDRVTITCRASEDIYSNLAWYQQKPGKAPKLLIYSVKRLQDGVPS
RFSGSGSGTDFTLTISSLQPEDFATYYCLQGSNFPLTFGQGTKVEIK Click to Show/Hide
|
|||||
| Light Chain CDR 1 |
RASEDIYSNLA
Click to Show/Hide
|
|||||
| Light Chain CDR 2 |
SVKRLQD
Click to Show/Hide
|
|||||
| Light Chain CDR 3 |
LQGSNFPLT
Click to Show/Hide
|
|||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
hCL1f-LC-G2-PNU [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
0.7948 ug/ml
|
High Claudin-18.2 expression (Claudin-18.2 +++) | ||
| Method Description |
A Cell line test on HEK293T
|
||||
| In Vitro Model | Normal | HEK293T cells | CVCL_0063 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal Effective Concentration (EC50) |
0.7948 ug/ml
|
High Claudin-18.2 expression (Claudin-18.2 +++) | ||
| Method Description |
A Cell line test on HEK293T
|
||||
| In Vitro Model | Normal | HEK293T cells | CVCL_0063 | ||